$ZURA
Zura Bio Limited Class A Ordinary Shares
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$4.15
▲+4.80%+$0.190
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateZura Bio Limited Class A Ordinary Shares
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ZURA up today? It is at $4.15 (+4.80%), and our scanner flagged it 85 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ZURA spikes, and full due diligence on ZURA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ZURA 85 times in the last 30 days. Create a free account to track $ZURA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ZURA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ZURA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystsimilar expressions are intended to identify such forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on currentReported IL-17 and BAFF among the most clinically validated pathways in immunologic disorders1,2Reported Orthogonal nature of IL-17 and BAFF offers potential to modulate non-redundant pathwaysReported Potent engagement of targets and low immunogenicity observed in Phase 1, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ai Biotechnology Llc Beneficial Owner (10%) | Bought (open market) | +2.00M 2.1% of company | added 44% | 6.55M | $12.5M at $6.25 | Feb 26, 26 |
Thiara Parvinder Director | Sold (automatic/other) | -1.00M 1.0% of company | n/a | n/a | $2.7M at $2.73 | Nov 25, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on ZURA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ZURA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ZURA last traded at $4.15, up 4.80% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Zura Bio Limited Class A Ordinary Shares (ZURA) is next expected to report earnings on Thursday, November 12, 2026, about 36 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ZURA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ZURA 85 times in the last 30 days.
ZURA (Zura Bio Limited Class A Ordinary Shares) trades on XNAS, with a market cap of about $400M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ZURA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ZURA discussion
Sign in to ask a question or join the discussion.